Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03647111
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2018-08-23
Brief Title:
Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer
Sponsor:
Hunan Province Tumor Hospital
Organization:
Hunan Province Tumor Hospital
Organization Data
Organization:
Hunan Province Tumor Hospital
Class:
OTHER
Study ID:
RECURE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hunan Province Tumor Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Yongchang Zhang
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hunan Province Tumor Hospital
Old Name:
None
Old Organization:
None